 Provider News KentuckyFebruary 1, 2024 February 2024 Provider Newsletter Contents
KYBCBS-CDCRCM-048967-24 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Please review your online provider directory information on a regular basis to ensure it is correct. Access your online provider directory information by visiting anthem.com, then at the top of the webpage, select Find Care. Submit updates and corrections to your directory information by following the instructions on the Provider Maintenance Form online. Update options include: - add/change an address location
- name change
- phone/fax number change
- provider leaving a group or a single location
- closing a practice location
The Consolidated Appropriations Act (CAA) implemented in 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. By reviewing your information regularly, you help us ensure your online provider directory information is current. We share a health vision with our care providers that means real change for consumers. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-049338-24 This article was published in error and retracted on February 21, 2024. Please access your state's updated version: Colorado, Connecticut, Georgia, Indiana, Kentucy, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, Wisconsin You may submit all your prior authorizations in one application on Availity.com.
You may already be submitting your prior authorizations through the Availity multi-payer Authorization application — taking advantage of the time savings and speed to care through digital authorization submissions. Beginning in March, you can submit both your physical health and behavioral health prior authorizations through one Authorization application on Availity.com.
You can still access the Interactive Care Reviewer (ICR) to review cases that were submitted through that application. You will also continue to use ICR to submit an appeal or authorization for medical specialty Rx.
Using the Availity Authorization application to submit your behavioral health prior authorizations will not be much different from the process you follow today. You may enjoy more intuitive screens or learn sooner if an authorization is required — but the digital submission process is still the very best way to submit your prior authorization and the fastest way to care for our members.
Training is available
If you aren’t already familiar with Availity Authorization, training is available. Select Availity Authorization Training to enroll for an upcoming live webcast or to access an on-demand recording.
Now, give it a try!
Accessing the Availity for authorization is easy. Ask your organization’s Availity administrator to ensure you have the Authorization role assignment. Without the role assignment, you will not be able to access the Authorization application. Then, log on to Availity.com to access the app through the Patient Registration tab by selecting Authorizations and Referrals.
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-049149-23-CPN48082 Now accepting Medicaid and Medicare member claimsAs a care provider taking advantage of digital requests for additional information (Digital RFAI), you know it is the most efficient way to send the required documentation to process your Commercial member claims. As of February, you also can receive Digital RFAI notifications for your Medicaid and Medicare member claims. The process will not change for Medicaid and Medicare member claims. You will still follow the same fast and easy process for our Medicaid and Medicare member claims as you do for your commercial member claims. The only difference is that your Medicaid and Medicare member claims will not pend. Medicaid and Medicare member claims will deny when additional documentation is needed to process the claim.* Notifications will remain on your dashboard for up to 30 days for pended claims as they do today and 45 days for denied claims. After that, those notifications will move to the history tab of your dashboard.. Submit the documentation at your convenience (most care providers submit documents within seven to 14 days). Your notifications will continue to arrive on your dashboard each morning, making it convenient to plan your work; no need to check your dashboard throughout the day. * Claims for providers under pre-payment review will pend for 30 days. Learn more!In collaboration with Availity, we’ve developed training for your organization’s administrators about how to update the Medical Attachment registration.: Availity administrators can use this link to register for live training or to view the training on demand. For associates who are responsible for sending attachments, we’ve developed an enhanced training session that walks through the Attachments Dashboard and many of the unique features that make it most efficient. Availity users with the Medical Attachments and Claims Status role assignment can use this link to register for live training, or to view the live training on-demand. Contact Availity Customer Support at availity.com/Contact-Us or your provider relationship representative if you have any questions. Not a Digital RFAI care provider?If you’re not already using the Digital RFAI process and want to take advantage of faster claims processing, participation is easy. 1. | Registration | The organization’s Availity administrator will register for Medical Attachments, which enables care provider organizations to receive notices from the payer and submit requested documents digitally. | All billing NPIs/TINs must be registered. | 2. | User roles | The Availity administrator will be required to update or add new users with these specific role assignments through Availity: - Claims Status
- Medical Attachments
| Enable users to view the Availity Attachment Dashboard. | 3. | Ready to go! | After the registration and user roles are completed on Availity, the Digital RFAI process is ready. | Requests will automatically appear on the Attachments Dashboard each morning (when documents are needed). |
We are committed to finding solutions that help our care provider partners offer quality services to our members. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-049152-23-CPN48758 Anthem wants to remind you of a training resource that’s available for all providers. It’s called Provider Pathways, an on-demand digital eLearning that’s comprised of a collection of topics called modules. Each module covers a different aspect of doing business with Anthem. Depending on what you need, you can take one or all the modules. How to find Provider PathwaysProvider Pathways — Doing Business with eLearning for Anthem gives you the flexibility for scheduling training for yourself and your staff. You can find this training on the provider website: - Go to https://providers.anthem.com/ky
- Select Training Academy under Resources in the top navigation.
- Once on the site, select Provider Pathways under Training Resources.
If you have questions about this provider resource, please reach out to your Healthcare Networks team. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. KYBCBS-CD-043772-23-CPN40326 ATTACHMENTS (available on web): Provider Pathways — Learn all about it (pdf - 0.33mb) SummaryOn September 21, 2023, and October 4, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | February 19, 2024 | *CC-0248 | Elrexfio (elranatamab-bcmm) | New | February 19, 2024 | *CC-0249 | Talvey (talquetamab-tgvs) | New | February 19, 2024 | *CC-0250 | Veopoz (pozelimab-bbfg) | New | February 19, 2024 | *CC-0251 | Pompe Disease | New | February 19, 2024 | *CC-0018 | Pompe Disease | Revised | February 19, 2024 | *CC-0021 | Fabrazyme (agalsidase beta) | Revised | February 19, 2024 | *CC-0046 | Zinplava (bezlotoxumab) | Revised | February 19, 2024 | CC-0182 | Iron Agents | Revised | February 19, 2024 | *CC-0068 | Growth Hormones | Revised | February 19, 2024 | CC-0156 | Reblozyl (luspatercept) | Revised | February 19, 2024 | *CC-0233 | Rebyota (fecal microbiota, live – jslm) | Revised | February 19, 2024 | *CC-0020 | Natalizumab Agents (Tysabri, Tyruko) | Revised | February 19, 2024 | CC-0064 | Interleukin-1 Inhibitors | Revised | February 19, 2024 | CC-0026 | Testosterone Injectable | Revised | February 19, 2024 | *CC-0247 | Beyfortus (nirsevimab) | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-047335-23-CPN47070 Effective June 1, 2024, Anthem will transition from CG-BEH-02 (Adaptive Behavioral Treatment) and MCG W0153 (Behavioral Health Care Applied Behavioral Analysis), to MCG B-806-T Behavioral Health Care Applied Behavioral Analysis (Original MCG Guideline), for medical necessity/clinical appropriateness reviews. If you have questions, please contact the provider service number on the back of the member's ID card. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047274-23 Effective for dates of service on and after May 1, 2024, the following codes will require prior authorization through Carelon Medical Benefits Management, Inc. CPT® code | Description | 0239U | Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations | 0306U | Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations | 0307U | Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient specific panel for | 0356U | Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement | 0368U | Oncology (colorectal cancer), evaluation for mutations of APC, BRAF, CTNNB1, KRAS, NRAS, PIK3CA, SMAD4, and TP53, and methylation markers (MYO1G, KCNQ5, C9ORF50, FLI1, CLIP4, ZNF132 and TWIST1), multiplex quantitative polymerase chain reaction (qPCR), circulating cell-free DNA (cfDNA), plasma, report of risk score for advanced adenoma or colorectal cancer | 0326U | Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden |
As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management in one of several ways: - Access the ProviderPortalSM directly at providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
- Access via Availity.com.
If you have questions related to guidelines, please contact Carelon via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. With your help, we can continually build towards a future of shared success. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-048270-23-CPN48141 Effective for dates of service on and after April 14, 2024, the following updates will apply to the Carelon Medical Benefits Management Clinical Appropriateness Guidelines. As part of the Carelon Medical Benefits Management guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services. Radiology Imaging of the heartCardiac CT Cardiomyopathy: Added specificity to establish the basis for the suspicion of ARVD. This change aligns with Cardiac MRI guidelines. Resting Transthoracic Echocardiography (TTE) Evaluation of ventricular function: New indications for evaluation of patients on mavacamten for treatment of HOCM Imaging of the abdomen and pelvisBiliary tract dilatation or obstruction: Added indication for annual surveillance in Caroli disease/syndrome based on a 2022 guideline recommendation. Diffuse liver disease: Removed indication for LiverMultiScan in hemochromatosis as there is insufficient evidence that this provides an advantage over standard MRI for this condition Osteomyelitis: Added requirement for initial evaluation with radiographs in adult patients based on ACR appropriateness criteria. Septic arthritis: Added requirement for initial radiographs in adult patients based on ACR appropriateness criteria Pancreatic mass, indeterminate cystic (IPMN/IPMT): For enlarging lesions in patients age 80 or greater, increased surveillance frequency to annually and removed endpoint of 4 years. Pelvic floor disorders: Added indication for MRI (MR defecography preferred) in suspected pelvic organ prolapse based on ACR appropriateness criteria Transplant-related imaging: Added indication for single CT abdomen or abdomen/pelvis prior to lung, kidney, or stem cell transplant to align with CT chest guidelines. Imaging of the brain Movement disorders (Adult only): Added indication for CT head for assessment of skull density prior to MRgFUS for essential tremor
Trauma: Added a 3-6 week follow up study in patients age 6 or younger with stable or inconclusive exam, due to difficulty in accurately assessing for changes in neurologic status Acoustic neuroma: Added long-term follow-up intervals based on specialty society guidelines Imaging of the chestPerioperative or periprocedural evaluation, not otherwise specified Added indication for CT chest to be used for planning of biopsy or placement of fiducial markers using navigational bronchoscopy Imaging of the head and neckAcoustic neuroma: Added long-term follow-up intervals based on specialty society guidelines Localized facial pain (including trigeminal neuralgia): Added MRI orbit/face/neck for this indication based on ACR criteria; some facilities use MRI face rather than brain for this condition Oncologic imagingCancer screeningBreast cancer screening Addition of high-risk genetic mutations (NCCN alignment citing absolute risk of 20% or greater) Lung cancer screening Clarification of asbestos-related lung disease as risk factor independent of smoking, aligned with original intent. Pancreatic cancer screening Alignment with NCCN recommended parameters; changes are overall expansive, except for: Older start age (from 45 to 50) for certain genes (ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6, EPCAM, PALB2, TP53) Family history alone (relative requirement) Breast cancer CT chest, CT abdomen and pelvis: Added diagnostic workup allowance when metastatic disease is clinically suspected at presentation MRI Breast: Addition/clarification of surveillance scenarios aligned with NCCN/ACR considerations FDG-PET/CT: Added allowance for RT planning locoregional recurrence (for example, confirmation of regional nodal involvement) 18F-fluoroestradiol (18F-FES) PET/CT: Added that it Is not indicated due to uncertain net benefit; low-level evidence, insufficient data on outcomes. Cervical cancer FDG-PET/CT: Update for follow-up of disease treated with either adjuvant RT or chemoradiation (NCCN alignment). Hepatocellular and Biliary Tract Cancers FDG-PET/CT: Removed routine preop PET/CT for biliary tract cancers (NCCN alignment) FDG-PET/CT: Added management allowance when standard imaging cannot be done or is nondiagnostic (NCCN "consider" for equivocal finding) Lung cancer – non-small cell FDG-PET/CT: Added management allowance when recurrence demonstrated by surveillance imaging (NCCN alignment) Lung cancer – small cell FDG-PET/CT: Clarification of initial staging allowance (NCCN alignment) Lymphoma – Non-Hodgkin and Leukemia FDG-PET/CT: NCCN alignment for interim restaging (allowed for DLBCL stage I-IV with or without bulky disease) Melanoma Added surveillance option with MRI abdomen for liver metastases. Prostate cancer 18F Fluciclovine PET/CT or 11C Choline PET/CT, 68GaProstate-specific membrane antigen (PSMA) PET/CT or 18F-DCFPyL (piflufolastat or Pylarify) PET/CT Addition of diagnostic workup/initial staging indication. Specification of androgen-receptor pathway inhibitor treatment in alignment with Carelon Medical Benefits Management Radiation Oncology Guidelines. Sarcomas of bone/soft tissue FDG-PET/CT: Added allowance when standard imaging nondiagnostic or contraindicated (bone/soft tissue sarcoma). As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management using the following: - Access Carelon’s Medical Benefits Management ProviderPortalSM directly at providerportal.com.
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
For questions related to guidelines, please contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. KYBCBS-CD-042357-23-CPN42014 As part of our ongoing quality improvement efforts, we will be implementing a new Genetic Testing (GT) claim to authorization match enhancement that will ensure GT panels billed have a corresponding authorization. This enhanced match logic will be effective by May 1, 2024. Labs that bill panels with codes in excess of what has been authorized may receive a full claim denial. The goal of this enhanced match logic is to ensure tests performed are authorized and meet medical necessity requirements. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047632-23-CPN47301 Effective February 1, 2024, prior authorization (PA) requirements will change for the following code. The medical code listed below will require PA by Anthem for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | J1411 | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose |
To request PA, you may use one of the following methods: - Web: Availity Essentials platform at Availity.com.
- Fax: 800-964-3627
- Phone: 855-661-2028
Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://providers.anthem.com/ky on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 855-661-2028 for assistance with PA requirements. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. KYBCBS-CD-039439-23-CPN38396 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA for Anthem Blue Cross and Blue Shield members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | E0761 | Non-Thermal Pulsed High Frequency Radiowaves, High Peak Power Electrom |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card for Provider Services. UM AROW #: A2023M0415 Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044184-23-CPN43845, CPN-CRMMP-049296-24 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0738T | Treatment planning for magnetic field induction ablation of malignant prostate tissue, using data from previously performed magnetic resonance imaging (MRI) examination | 0739T | Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and int |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements. UM AROW #: A2023M0443 Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044235-23-CPN43832, CPN-CRMMP-049296-24 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | Q4272 | Esano a, per square centimeter | Q4273 | Esano aaa, per square centimeter | Q4274 | Esano ac, per square centimeter | Q4275 | Esano aca, per square centimeter | Q4276 | Orion, per square centimeter | Q4277 | Woundplus membrane or e-graft, per square centimeter | Q4278 | Epieffect, per square centimeter | Q4280 | Xcell amnio matrix, per square centimeter | Q4281 | Barrera sl or barrera dl, per square centimeter | Q4282 | Cygnus dual, per square centimeter | Q4283 | Biovance tri-layer or biovance 3l, per square centimeter | Q4284 | Dermabind sl, per square centimeter |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements. UM AROW #: A2023M0417 Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044198-23-CPN43849, CPN-CRMMP-049296-24 Beginning with dates of service on or after May 1, 2024, Anthem will implement a new reimbursement policy titled Modifier Usage — Facility based on the code-set combinations submitted with the correct modifiers. This reimbursement policy identifies the following three different types of facility modifiers: - Reimbursement modifiers affect payment and denote circumstances when an increase or reduction is appropriate for the service provided.
- Informational modifiers impacting reimbursement determine if the service provided will be reimbursed or denied.
- Informational modifiers not impacting reimbursement are used for documentation purposes.
The Related Coding section of the policy includes a Facility Modifier code list which identifies the modifier, the modifier description, and any related reimbursement policies. The Facility Modifier code list also includes six modifiers that do not have associated reimbursement policies. These modifiers indicate a reduced service or different equipment was used for the service. These modifiers will result in a reduction when billed on a facility claim. For specific policy details, visit the reimbursement policy page at anthem.com. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047155-23-SRS47155 Beginning with dates of service on or after April 1, 2024, Anthem will not reimburse for the following when billed on a UB-04: - Consultation CPT® codes 99242–99245, 99251–99255
- Prolonged Services codes 99354–99359, 99415–99417 and G2212
For appropriate billing guidelines of Consultation and Prolonged Services CPT codes, please refer to the corresponding professional Reimbursement Policies: - Prolonged Services
- Consultation Services
For specific policy details, visit the reimbursement policy page at anthem.com. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047188-23 This article was updated on July 23, 2024 to correct the Clinical Criteria for Spravato (esketamine) from CC-0066 to CC-0086. Specialty pharmacy updates for Anthem are listed belowPrior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s Medical Specialty Drug Review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code. Prior authorization updatesUpdate: In the May 2023 edition of Provider News, we announced prior authorization for Adstiladrin will be effective August 2023. Review of Adstiladrin is managed by Carelon Medical Benefits Management. Effective for dates of service on and after May 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0252 | Adzynma (ADAMTS13, recombinant-krhn) | C9399 | CC-0253* | Aphexda (motixafortide) | J3490, J3590, J9999 | CC-0042 | Bimzelx (bimekizumab-bkzx) | J3490 | CC-0032 | Daxxify (daxibotulinumtoxinA-lanm) | C9160 | CC-0050 | Omvoh (mirikizumab-mrkz) | J3590 | CC-0066* | Tofidence (tocilizumab-bavi) | J3490, J3590 | CC-0254 | Zilbysq (zilucoplan) | J3490 | CC-0062 | Zymfentra (infliximab-dyyb) | J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Quantity limit updatesEffective for dates of service on and after May 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0042 | Bimzelx (bimekizumab-bkzx) | J3490 | CC-0032 | Daxxify (daxibotulinumtoxinA-lanm) | C9160 | CC-0050 | Omvoh (mirikizumab-mrkz) | J3590 | CC-0066 | Tofidence (tocilizumab-bavi) | J3490, J3590 | CC-0254 | Zilbysq (zilucoplan) | J3490 | CC-0062 | Zymfentra (infliximab-dyyb) | J3590 | CC-0086 | Spravato (esketamine) | G2082, G2083, S0013 |
Through our efforts, we are committed to reducing administrative burden and ensuring timely payments because we value you, our care provider partners. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-048938-24-CPN48884 This article was published in error and retracted on February 23, 2024. Please access your state's updated version: Colorado, Connecticut, Georgia, Indiana, Kentucy, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, Wisconsin Effective for dates of service on and after May 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.
Federal and state law, as well as state contract language and CMS guidelines (including definitions and specific contract provisions/exclusions), take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
HCPCS or CPT® codes
| Medicare Part B drugs
| J3490, J3590, J9999, C9399
| Elrexfio (elranatamab-bcmm)
| J3490, J3590
| Eylea HD (aflibercept)
| J3490, J3590
| Pombiliti (cipaglucosidase alfa-atga)
| J3490, J3590, J9999, C9399
| Talvey (talquetamab-tgvs)
| J3490, J3590
| Tyruko (natalizumab-sztn)
| J3590, C9399
| Veopoz (pozelimab-bbfg)
| J3490
| Ycanth (cantharidin)
|
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-046706-23-CPN45768 Hispanics are the largest ethnic minority group in the United States, making it vital that we recognize the unique health needs of the population. Take time in February to support American Heart Health Month and explore how your practice can help improve your Hispanic patients’ heart health. What can your practice do to help improve health outcomes for Hispanic patients with heart disease?- Be proactive about asking if the patient requires interpretation services. No one wants to feel like a burden. By asking and preparing for an interpreter in advance, you are creating a welcoming atmosphere for the patient during their appointment. If you would like to request an interpreter, including sign language, on behalf of your Anthem Blue Cross and Blue Shield patients, call Provider Services. Free interpreter services are also available to members by calling the Member's Services number on the back of their ID card (TTY/TTD 711) and through the 24/7 NurseLine.
- According to a study by the American Heart Association (link), Hispanic persons had similar rates of heart disease compared to Caucasian adults but lower rates of awareness and control. To help increase awareness of their condition, you can ask questions such as:
- “Have you ever been told that you have high blood pressure or high cholesterol?”
- “Has a healthcare provider ever discussed with you or prescribed you medication to control your blood pressure or cholesterol levels?”
- Once awareness of the condition is properly understood, educate the patient on any increased health risk factors they might have, especially if they have other conditions like diabetes or obesity.
- Use culturally appropriate examples when discussing lifestyle changes. Select here for our conversation guide for tips on how to engage patients who may be from a culture different from your own.
- Encourage scheduling follow-up appointments for blood pressure rechecks or lab work to check cholesterol levels before the patient leaves the office.
- Submit all blood pressure readings using Category II codes on claims or through your practice’s preferred supplemental data submission method. Blood pressure care gaps can open and close through the year and are based on the last recorded blood pressure reading of the year. The goal for every patient is a reading below 140/90 mmHg.
- Properly code statin therapy exclusions and prescribe low-cost medications to discourage the use of discount cards.
To learn more about our commitment to health equity, visit MyDiversePatients.com. Your patients can also learn more about the unique health needs of Hispanic persons by visiting takingactionforourhealth.org/. Patient care opportunitiesIf you have questions on improving your quality scores, contact your care consultant or program manager to discuss your opportunities. You also can find patient care opportunities within the Patient360 application located on Availity Essentials Payer Spaces. To access the Patient360 application you must have the Patient360 role assignment. From Availity’s home page, select Payer Spaces, then choose the health plan from the menu. Choose the Patient360 tile from the Payer Space Applications menu and complete the required information on the screen. Gaps in care are in the Active Alerts section of the Member Summary. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management associate or call Provider Services on the back of your patient’s member ID card. Through our efforts, we can help deliver high quality, equitable healthcare. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-040701-23-CPN39313 Hispanics are the largest ethnic minority group in the United States, making it vital that we recognize the unique health needs of the population. Take time in February to support American Heart Health Month and explore how your practice can help improve your Hispanic patients’ heart health. What can your practice do to help improve health outcomes for Hispanic patients with heart disease?- Be proactive about asking if the patient requires interpretation services. No one wants to feel like a burden. By asking and preparing for an interpreter in advance, you are creating a welcoming atmosphere for the patient during their appointment. If you would like to request an interpreter, including sign language, on behalf of your Anthem Blue Cross and Blue Shield patients, call Provider Services. Free interpreter services are also available to members by calling the Member's Services number on the back of their ID card (TTY/TTD 711) and through the 24/7 NurseLine.
- According to a study by the American Heart Association (link), Hispanic persons had similar rates of heart disease compared to Caucasian adults but lower rates of awareness and control. To help increase awareness of their condition, you can ask questions such as:
- “Have you ever been told that you have high blood pressure or high cholesterol?”
- “Has a healthcare provider ever discussed with you or prescribed you medication to control your blood pressure or cholesterol levels?”
- Once awareness of the condition is properly understood, educate the patient on any increased health risk factors they might have, especially if they have other conditions like diabetes or obesity.
- Use culturally appropriate examples when discussing lifestyle changes. Select here for our conversation guide for tips on how to engage patients who may be from a culture different from your own.
- Encourage scheduling follow-up appointments for blood pressure rechecks or lab work to check cholesterol levels before the patient leaves the office.
- Submit all blood pressure readings using Category II codes on claims or through your practice’s preferred supplemental data submission method. Blood pressure care gaps can open and close through the year and are based on the last recorded blood pressure reading of the year. The goal for every patient is a reading below 140/90 mmHg.
- Properly code statin therapy exclusions and prescribe low-cost medications to discourage the use of discount cards.
To learn more about our commitment to health equity, visit MyDiversePatients.com. Your patients can also learn more about the unique health needs of Hispanic persons by visiting takingactionforourhealth.org/. Patient care opportunitiesIf you have questions on improving your quality scores, contact your care consultant or program manager to discuss your opportunities. You also can find patient care opportunities within the Patient360 application located on Availity Essentials Payer Spaces. To access the Patient360 application you must have the Patient360 role assignment. From Availity’s home page, select Payer Spaces, then choose the health plan from the menu. Choose the Patient360 tile from the Payer Space Applications menu and complete the required information on the screen. Gaps in care are in the Active Alerts section of the Member Summary. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management associate or call Provider Services on the back of your patient’s member ID card. Through our efforts, we can help deliver high quality, equitable healthcare. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-040702-23-CPN39313 Hispanics are the largest ethnic minority group in the United States, making it vital that we recognize the unique health needs of the population. Take time in February to support American Heart Health Month and explore how your practice can help improve your Hispanic patients’ heart health. What can your practice do to help improve health outcomes for Hispanic patients with heart disease?- Be proactive about asking if the patient requires interpretation services. No one wants to feel like a burden. By asking and preparing for an interpreter in advance, you are creating a welcoming atmosphere for the patient during their appointment. If you would like to request an interpreter, including sign language, on behalf of your Anthem Blue Cross and Blue Shield Medicaid patients, call Provider Services. Free interpreter services are also available to members by calling the Member's Services number on the back of their ID card (TTY/TTD 711) and through the 24/7 NurseLine.
- According to a study by the American Heart Association (link), Hispanic persons had similar rates of heart disease compared to Caucasian adults but lower rates of awareness and control. To help increase awareness of their condition, you can ask questions such as:
- “Have you ever been told that you have high blood pressure or high cholesterol?”
- “Has a healthcare provider ever discussed with you or prescribed you medication to control your blood pressure or cholesterol levels?”
- Once awareness of the condition is properly understood, educate the patient on any increased health risk factors they might have, especially if they have other conditions like diabetes or obesity.
- Use culturally appropriate examples when discussing lifestyle changes.
- Encourage scheduling follow-up appointments for blood pressure rechecks or lab work to check cholesterol levels before the patient leaves the office.
- Submit all blood pressure readings using Category II codes on claims or through your practice’s preferred supplemental data submission method. Blood pressure care gaps can open and close through the year and are based on the last recorded blood pressure reading of the year. The goal for every patient is a reading below 140/90 mmHg.
- Properly code statin therapy exclusions and prescribe low-cost medications to discourage the use of discount cards.
To learn more about our commitment to health equity, visit MyDiversePatients.com. Your patients can also learn more about the unique health needs of Hispanic persons by visiting takingactionforourhealth.org/. Patient care opportunitiesIf you have questions on improving your quality scores, contact your care consultant or program manager to discuss your opportunities. You also can find patient care opportunities within the Patient360 application located on Availity Essentials Payer Spaces. To access the Patient360 application you must have the Patient360 role assignment. From Availity’s home page, select Payer Spaces, then choose the health plan from the menu. Choose the Patient360 tile from the Payer Space Applications menu and complete the required information on the screen. Gaps in care are in the Active Alerts section of the Member Summary. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management associate or call Provider Services at 855-661-2028. Through our efforts, we can help deliver high quality, equitable healthcare. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. KYBCBS-CD-040690-23-CPN39313 Measure descriptionThe percentage of discharges for members 18 years of age and older who had each of the following: - Notification of inpatient admission (can only be captured through medical record review)
- Receipt of discharge information (can only be captured through medical record review)
- Patient engagement after inpatient discharge
- Medication reconciliation post-discharge
What we are looking for in care provider records:- Notification of inpatient admission — Documentation in the outpatient medical record must include evidence of receipt for notification of inpatient admission on the day of admission through two days after the admission (three total days) with evidence of the date when the documentation was received. Any of the following examples meet criteria:
- Communication about admission between inpatient care inpatient providers, staff, or ER, and the member’s PCP or ongoing care provider (for example, phone call, e-mail, fax, information exchange, automated alert system, shared electronic medical record, or from the member’s health plan)
- Indication that the PCP or ongoing care provider admitted the member to the hospital
- Indication that a specialist admitted the member to the hospital and notified the member’s PCP or ongoing care provider
- Indication that the PCP or ongoing care provider placed orders for tests and treatments any time during the member’s inpatient stay
- Documentation that the PCP or ongoing care provider performed a preadmission exam or received communication about a planned inpatient admission. The time frame that the preadmission exam or planned inpatient admission must be communicated is not limited to the day of admission through two days after the admission (three total days)
- Receipt of discharge information — Documentation in the outpatient medical record must include evidence of receipt of discharge information on the day of discharge through two days after the discharge (three total days) with evidence of the date when the documentation was received. Discharge information may be included in, but not limited to, a discharge summary or summary of care record, or in the structured fields in an electronic health record. At a minimum, the discharge information must include the following:
- The practitioner responsible for the member’s care during the inpatient stay
- Procedures or treatments provided
- Diagnoses at discharge
- Current medication list
- Testing results, or documentation of pending tests or no tests pending
- Instructions for patient care post-discharge
- Patient engagement after inpatient discharge — Documentation in the outpatient medical record must include evidence of patient engagement within 30 days after discharge. Any of the following meet criteria:
- An outpatient visit, including office visits and home visits
- A telephone visit
- A synchronous telehealth visit where real-time interaction occurred between the member and care provider using audio and video communication
- An e-visit or virtual check-in (asynchronous telehealth where two-way interaction, which was not real-time, occurred between the member and care provider)
- Medication reconciliation post-discharge — Documentation in the outpatient medical record must include evidence of medication reconciliation and the date when it was performed. Medication reconciliation must be conducted by a prescribing practitioner, clinical pharmacist, physician assistant, or registered nurse. Any of the following meet criteria:
- Documentation of the current medications with a notation that the care provider reconciled the current and discharge medications
- Documentation of the current medications with a notation that references the discharge medications (for example, no changes in medications since discharge, same medication at discharge, discontinue all discharge medications)
- Documentation of the member’s current medications with a notation that the discharge medications were reviewed
- Documentation of a current medication list, a discharge medication list and notation that both lists were reviewed on the same date of service
- Documentation of the current medications with evidence that the member was seen for post-discharge hospital follow-up with evidence of medication reconciliation or review:
- Evidence that the member was seen for post-discharge follow-up requires documentation that indicates the care provider was aware of the member’s hospitalization or discharge
- Documentation in the discharge summary that the discharge medications were reconciled with the most recent medication list in the outpatient medical record. There must be evidence the discharge summary was filed in the outpatient chart on the date of discharge through 30 days after discharge (31 total days).
- Notation that no medications were prescribed or ordered upon discharge
- Exclusions:
- Evidence of hospice or palliative services in 2023
- Evidence patient expired in 2023
Helpful hints:- Documentation of a procedure/surgery that is typically performed inpatient (such as, aortic bypass) does not indicate that the care provider is aware of the hospitalization. Documentation of post-op/surgery follow-up alone does not indicate the care provider was aware of the hospitalization or discharge. Make sure documentation references the hospitalization, admission, or inpatient stay.
- If performing a pre-admission exam, document that it is a pre-admission exam.
- If performing a pre-surgical, pre-operative, or surgical clearance exam, the date of the admission must be documented.
- Implement process to receive automated alerts when a member is admitted or discharged from an inpatient facility.
- Review discharge medications with the member.
- Schedule post-hospital discharge following appointments and have the office call the member to remind them.
- Document a received date for discharge summaries and notification of inpatient admissions.
- Use the appropriate billing codes for Medication Reconciliation Post-Discharge and Patient Engagement After Inpatient Discharge.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. KYBCBS-CD-038727-23-CPN38596 |